XML 17 R3.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Revenue $ 58,853 $ 28,222 $ 112,083 $ 73,731
Costs and expenses:        
Partner Share and other third-party costs 29,953 16,811 59,724 42,949
Delivery costs 5,748 3,499 9,686 6,905
Sales and marketing expense 17,063 10,405 30,265 21,373
Research and development expense 8,934 3,966 15,152 7,817
General and administration expense 16,888 11,734 29,063 22,478
Acquisition and integration costs 14,182 0 21,212 0
Depreciation and amortization expense 8,833 1,545 11,898 3,876
Total costs and expenses 101,601 47,960 177,000 105,398
Operating loss (42,748) (19,738) (64,917) (31,667)
Other (expense) income:        
Interest (expense) income, net (3,078) (10) (6,123) 274
Change in fair value of contingent consideration (1,480) 0 (1,480) 0
Foreign currency (loss) gain 0 (10) 319 (1,896)
Total other expense (4,558) (20) (7,284) (1,622)
Loss before income taxes (47,306) (19,758) (72,201) (33,289)
Income tax benefit 0 0 0 0
Net loss (47,306) (19,758) (72,201) (33,289)
Net loss attributable to common stockholders $ (47,306) $ (19,758) $ (72,201) $ (33,289)
Net loss per share attributable to common stockholders, basic and diluted (in USD per share) $ (1.43) $ (0.73) $ (2.32) $ (1.24)
Weighted-average common shares outstanding, basic and diluted (in shares) 32,977 27,072 31,145 26,898